파이프라인
파이프라인
| Product | Target | Indication | Site | Pre | Phase1 | Phase2 | Phase3 |
|---|---|---|---|---|---|---|---|
| Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (mono) |
US KOR |
|
|||
|
mCRC, NSCLC, r/rMM, Desmoid etc. (combo) |
US KOR |
|
|||||
| MP010 | TME | Solid Tumors | - |
|
|||
| MP2021 | TM4SF19 |
Bone-meta, Osteoporosis, Arthritis |
- |
|
|||
| Product | Target | Indication | Site | Pre-clinical | Phase1 | Phase2 | Phase3 | |
|---|---|---|---|---|---|---|---|---|
|
Oncology Program |
Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (mono) |
US KOR |
US FDA ODD, RPDD, FTD and EU OMPD
|
|||
|
mCRC, NSCLC, r/rMM, Desmoid etc. (combo) |
US KOR |
Exploring indication expansion
|
||||||
| MP010 | TME | Solid Tumors | - |
|
||||
|
New Program |
MP2021 | TM4SF19 |
Bone-meta, Osteoporosis, Arthritis |
- |
|
|||